Abu Dhabi and Biocom California Establish Strategic Gateway Linking Two Leading Life Sciences Ecosystems

25 June 2026 | Thursday | News

Partnership connects California’s innovation network with Abu Dhabi’s HELM Cluster to accelerate health technology development, foster cross-border collaboration, and expand opportunities for biotech, pharma and medtech companies.

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Biocom California, one of the world's largest life sciences associations representing more than 1,800 biotechnology, pharmaceutical and medical technology organisations, have announced a strategic partnership that will create a formal gateway between Abu Dhabi and California's life sciences ecosystems. The collaboration will strengthen connectivity between innovators, researchers, investors and entrepreneurs across both markets, creating new opportunities to accelerate the development, validation and scaling of next-generation health solutions.

 

Through Biocom California, US-based biotechnology, pharmaceutical and medical technology leaders will be provided access to Abu Dhabi's intelligent life sciences ecosystem and living lab model, where discovery, validation and real-world implementation happen within a single environment.

H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, said: "The most successful life sciences ecosystems are those that can connect talent, research, investment and implementation across borders. Through this partnership with Biocom, we are creating a direct bridge between Abu Dhabi's intelligent life sciences ecosystem and one of the world's leading centres of life sciences innovation. For innovators, researchers, and investors, this creates new opportunities to access Abu Dhabi's living lab for intelligent life sciences, where scientific discoveries can be translated into real-world impact faster and at scale."

Joe Panetta, President Emeritus of Biocom said: " Biocom is honored to be partnering with the DoH under this important MOU. Abu Dhabi life science ecosystem is strategically focused and well supported for the creation of promising new and innovative life science therapies. Biocom reaches out actively to develop a network of partnerships in established and growing life science ecosystems around the world. Under this MOU we look forward to cooperating jointly in events, providing opportunities to find partners for companies in both California and Abu Dhabi and connecting Abu Dhabi to our other partners."

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close